Takeda’s manufacturing site in Belgium gets a €300M boost for plasma therapy production
While pharma giant Takeda has been expanding its presence in R&D and manufacturing throughout the US and Asia over the past year, its latest move will see the company making a nine-figure investment in Europe.
Takeda will pump €300 million ($299 million) into expanding its manufacturing site in Lessines, Belgium, a city around 30 miles southwest of Brussels. The expansion will aim to increase the manufacturing of plasma-derived therapies. Takeda also said that this is the largest investment the company had made in Belgium.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.